News
CDC expands definition of COVID-19 exposure from ‘close contact’
October 23, 2020
Four factors associated with higher risk for transmission are the proximity of each encounter, its duration, whether an interaction takes place indoors or outdoors, and the number of people encountered.
News
FDA approves remdesivir, first treatment for COVID-19
October 22, 2020
The FDA also issued a new EUA for remdesivir allowing treatment of hospitalized pediatric patients younger than 12 weighing at least 3.5 kg.
News
Rinse and repeat? Mouthwash might mitigate COVID-19 spread
October 22, 2020
"I would recommend the use of the rinses on top of wearing mask and social distancing. This could add a layer of protection for yourself and others."
News
Brazil confirms death of volunteer in COVID-19 vaccine trial
October 21, 2020
The vaccine was developed by Oxford University and Astra Zeneca.
News
Survey: Acceptance of COVID-19 vaccine dips below 50%
October 21, 2020
Willingness to get such a vaccine has been steadily dropping since April.
Opinion
When the only clinical choices are ‘lose-lose’
October 21, 2020
The current pandemic has provided innumerable situations that can increase the risk for moral injury, said Dr. Peter Yellowlees.
News
Latest week brings 44,000 more children with COVID-19
October 21, 2020
California has the most cumulative child cases, and Texas has the most deaths.
News
COVID-19 antibody response not reduced with diabetes
October 20, 2020
Findings provide “cautious optimism” that a COVID-19 vaccine would be expected to work as well in people with diabetes as those without.
News
Survey: Doctors lonely, burned out in COVID-19
October 19, 2020
“Many other physicians may be going through versions of what I experienced, and I want to encourage them to get help if they’re feeling stressed, anxious, lonely, depressed, or burned out, and to recognize that they are not alone.”
News
Fauci: Cautious optimism for COVID-19 vaccine by end of 2020
October 18, 2020
Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.